Total tumor volume as a predictor of survival in patients with multiple oligometastases treated with stereotactic ablative radiotherapy (SABR)

被引：0
|
作者：
Ciro Franzese
Veronica Vernier
Davide Franceschini
Tiziana Comito
Pierina Navarria
Elena Clerici
Maria Ausilia Teriaca
Maria Massaro
Luciana Di Cristina
Beatrice Marini
Carmela Galdieri
Pietro Mancosu
Stefano Tomatis
Marta Scorsetti
机构：
[1] Humanitas University,Department of Biomedical Sciences
[2] IRCCS Humanitas Research Hospital,Department of Radiotherapy and Radiosurgery
来源：
Journal of Cancer Research and Clinical Oncology | 2023年 / 149卷
关键词：
Oligometastatic; SBRT; SABR; Stereotactic radiotherapy; Oligometastases; Multiple; Radiosurgery; Stereotactic ablative radiotherapy;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：10495 / 10503
页数：8
相关论文
共 50 条
  • [41] Local tumor control in patients with neuroendocrine neoplasms treated with stereotactic ablative radiotherapy (SBRT)
    Nygaard, Dowler A.
    Aggerholm, Pedersen N.
    Knap, Marquard M.
    Dam, G.
    Tabaksblat, E.
    JOURNAL OF NEUROENDOCRINOLOGY, 2023, 35 : 166 - 166
  • [42] INFLUENCE OF TUMOR HYPOXIA ON STEREOTACTIC ABLATIVE RADIOTHERAPY (SABR): RESPONSE TO DRS. MEYER AND TIMMERMAN
    Brown, Martin
    Lao, Billy
    Diehn, Maximillian
    Carlson, David
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2011, 79 (05): : 1600 - 1600
  • [43] Factors Affecting Use of Stereotactic Ablative Radiotherapy (SABR) in Patients with Inoperable Lung Cancer
    Syed, Mohshin
    Jayasekera, Geeshath
    Rushd, Farwah
    LUNG CANCER, 2025, 200
  • [44] Population Based Phase II Trial of Stereotactic Ablative Radiotherapy (SABR): Overall Survival Results of the SABR-5 Trial
    Jiang, W. N.
    Baker, S.
    Liu, M.
    Bergman, A.
    Schellenberg, D.
    Mou, B.
    Alexander, A. S.
    Carolan, H.
    Atrchian, S.
    Chan, E. K.
    Mohamed, I. G.
    Berrang, T.
    Bang, A.
    Chng, N.
    Matthews, Q.
    Pai, H. H.
    Lefresne, S.
    Tyldesley, S.
    Olson, R. A.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2022, 114 (03): : S147 - S148
  • [45] Detection of Circulating Tumor DNA After Stereotactic Ablative Radiotherapy in Patients With Unbiopsied Lung Tumors (SABR-DETECT)
    Verma, Saurav
    Young, Sympascho
    Kennedy, Thomas A. C.
    Carvalhana, Ilda
    Black, Morgan
    Baer, Kathie
    Churchman, Emma
    Warner, Andrew
    Allan, Alison L.
    Izaguirre-Carbonell, Jesus
    Dhani, Harmeet
    Louie, Alexander, V
    Palma, David A.
    Breadner, Daniel A.
    CLINICAL LUNG CANCER, 2024, 25 (02) : e87 - e91
  • [46] SHOULD ORGANS AT RISK (OARS) BE PRIORITIZED OVER TARGET VOLUME COVERAGE IN STEREOTACTIC ABLATIVE RADIOTHERAPY (SABR) FOR OLIGOMETASTASES? A SECONDARY ANALYSIS OF THE POPULATION-BASED PHASE II SABR-5 TRIAL
    Cereno, Reno Eufemon
    Mou, Benjamin
    Baker, Sarah
    Chng, Nick
    Arbour, Gregory
    Bergman, Alanah
    Liu, Mitchell
    Schellenberg, Devin
    Matthews, Quinn
    Huang, Vicky
    Mestrovic, Ante
    Hyde, Derek
    Alexander, Abraham
    Carolan, Hannah
    Hsu, Fred
    Miller, Stacy
    Atrchian, Siavash
    Chan, Elisa
    Ho, Clement
    Mohamed, Islam
    Lin, Angela
    Berrang, Tanya
    Bang, Andrew
    Jiang, Will
    Lund, Chad
    Pai, Howard
    Valev, Boris
    Lefresne, Shilo
    Tyldesley, Scott
    Olson, Robert
    RADIOTHERAPY AND ONCOLOGY, 2023, 186 : S28 - S29
  • [47] Should organs at risk (OARs) be prioritized over target volume coverage in stereotactic ablative radiotherapy (SABR) for oligometastases? a secondary analysis of the population-based phase II SABR-5 trial
    Cereno, Reno Eufemon
    Mou, Benjamin
    Baker, Sarah
    Chng, Nick
    Arbour, Gregory
    Bergman, Alanah
    Liu, Mitchell
    Schellenberg, Devin
    Matthews, Quinn
    Huang, Vicky
    Mestrovic, Ante
    Hyde, Derek
    Alexander, Abraham
    Carolan, Hannah
    Hsu, Fred
    Miller, Stacy
    Atrchian, Siavash
    Chan, Elisa
    Ho, Clement
    Mohamed, Islam
    Lin, Angela
    Berrang, Tanya
    Bang, Andrew
    Jiang, Will
    Lund, Chad
    Pai, Howard
    Valev, Boris
    Lefresne, Shilo
    Tyldesley, Scott
    Olson, Robert A.
    RADIOTHERAPY AND ONCOLOGY, 2023, 182
  • [48] Can dosimetry affect local control and survival in patients with early-stage lung cancer treated with Stereotactic Ablative Radiotherapy (SABR)? An analysis of the UK's largest cohort of lung SABR patients
    Saha, Animesh
    Beasley, Matthew
    Hatton, Nathaniel
    Dickinson, Peter
    Franks, Kevin
    Clarke, Katy
    Jain, Pooja
    Teo, Mark
    Murray, Patrick
    Lilley, John
    ACTA ONCOLOGICA, 2021, 60 (04) : 505 - +
  • [49] Can Dosimetry Affect Overall Survival in Patients with Medically Inoperable Peripheral Early Stage Lung Cancer Treated with Stereotactic Ablative Radiotherapy (SABR)? An Analysis of 1300 Patients
    Saha, A.
    Beasley, M.
    Clarke, K.
    Jain, P.
    Dickinson, P.
    Snee, M.
    Murray, P.
    Teo, M.
    Rodda, S. L.
    Lilley, J.
    Franks, K. N.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2019, 105 (01): : E529 - E529
  • [50] Recommendations for dose calculations of lung cancer treatment plans treated with stereotactic ablative body radiotherapy (SABR)
    Devpura, S.
    Siddiqui, M. S.
    Chen, D.
    Liu, D.
    Li, H.
    Kumar, S.
    Gordon, J.
    Ajlouni, M.
    Movsas, B.
    Chetty, I. J.
    XVII INTERNATIONAL CONFERENCE ON THE USE OF COMPUTERS IN RADIATION THERAPY (ICCR 2013), 2014, 489
12345